Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma

Status:
Completed

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

The first purpose is to confirm or not the efficacy of only one administration of DepoCyte®.

Phase 2

PETHEMA Foundation